Publication | Closed Access

Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen

Allergic EncephalomyelitisDifferential EffectAllergyAutoimmune DiseaseImmunotoxicologyIron MetabolismAllergy MedicineMedicineImmunologyAutoimmunityToxicologyAgent DesferrioxaminePharmacologyNeuroimmunologyHypersensitivity